Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapy
Keywords: ترومبوز وریدی و وریدی; FVL; Factor V Leiden; POAT; Pharmacogenetic Optimization of Anticoagulation Therapy.; Factor V Leiden; Prevalence; European American; African American; Arterial and venous thrombosis;